UTEP team advances in developing vaccine for cutaneous leishmaniasis

(The University of Texas at El Paso) A research team at The University of Texas at El Paso is one step closer to developing an effective human vaccine for cutaneous leishmaniasis. During the team's more than four years of research at UTEP's Border Biomedical Research Center, they discovered a vaccine formulation that resulted in a 96 percent decrease in the lesions caused by the illness and showed an 86 percent protection rate from the disease in mice.
Source: EurekAlert! - Biology - Category: Biology Source Type: news